Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 4

DRUG MECHANISM OF INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING RESPONSIBILITIES

ACTION
DIVALPROEX The drug's anticonvulsant  Treatment of Contraindicated in patients Adverse effects: Before Administration
SODIUM activity may be related to acute manic or hypersensitive to drug and Sedation, tremor, emotional upset,  Check doctor’s order including the right
(ANTIEPILEPTIC) increased brain mixed episodes in those with hepatic depression, psychosis, aggression, medication (name and form) and right
500 mg 1 tab BID concentrations of gamma- associated with disease or significant hyperactivity, behavioural dosage.
aminobutyric acid bipolar disorder hepatic dysfunction, and in deterioration, weakness,  Prepare medication as indicated
(GABA), an inhibitory
with or without patients with a urea cycle suicidality, rash, petechiae,  Obtain liver function test results, platelet
neurotransmitter in the
CNS, by inhibiting psychotic disorder (UCD). pancreatitis, hemorrhage, bone count, and PT and INR before starting
enzymes that catabolize features marrow suppression, therapy, and monitor these values
GABA or block the  Treatment of thrombocytopenia, hepatotoxicity, periodically.
reuptake of GABA into bipolar mania erythema multiforme, Stevens-  Don't give syrup to patients who need
glia and nerve endings.  Prophylaxis of Johnson syndrome, sodium restriction. Check with
migraine hypersensitivity reactions prescriber.
headache During Administration
Side effects:  Verify patient’s identity
Drowsiness, GI upset, transient  Inform patient not to chew tablets or
increase in hair loss. capsules before swallowing them.
Swallow them whole to prevent local
irritation of mouth and throat.
 Administer the right drug with the right
dose at the right time
 State importance and purpose of the drug
to the patient

After Administration
 Adverse reactions may not be caused by
valproic acid alone because it's usually
used with other anticonvulsants.
 Divalproex sodium has a lower risk of
adverse GI reactions.
 Never withdraw drug suddenly because
sudden withdrawal may worsen seizures.
Call prescriber at once if adverse
reactions develop.
 Notify prescriber if tremors occur; a
dosage reduction may be needed.
 Monitor drug level. Therapeutic level is
50 to 100 mcg/ml.
 When converting patients from a brand-
name drug to a generic drug, use caution
because breakthrough seizures may occur
DRUG MECHANISM OF INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING RESPONSIBILITIES
ACTION
FLUPHENAZINE May block postsynaptic  Treatment of  Contraindications CNS: Ataxia, cerebral edema, Before Administration
DECANOATE dopamine receptor sites acute or chronic dizziness, 1. Monitor patient’s blood pressure routinely.
(ANTIPSYCHOTIC in the CNS. This action psychosis Blood dyscrasias, bone drowsiness, headache, insomnia, 2. Assess mental status (mood, behavior,
) may depress areas of marrow depression, lightheadedness, orientation).
500 mg 1 tab BID the brain that control cerebral arteriosclerosis, nervousness, seizures, slurred 3. Assess weight and BMI.
activity and aggression, coma, concomitant use of speech, syncope, worsening
4. Assess positive and negative symptoms of
including the cerebral psychotic
large amounts of another schizophrenia.
cortex, hypothalamus, symptoms
and limbic system. CNS depressant, coronary CV: AV conduction disorders, 5. Assess fluid intake and bowel function
artery disease, hepatic bradycardia, 6. Prepare drug aseptically and verify the right
dysfunction, cardiac arrest, dose. Render health teaching as appropriate.
hypersensitivity to hypercholesterolemia,
phenothiazines, hypertension, During Administration
myeloproliferative orthostatic hypotension, QT- 1. Verify patient’s identity using the chart and
interval
disorders, severe other patient and nurse’s confirmation.
prolongation, shock, ST-segment
2. Administer oral doses with food, milk, or a full
CNS depression, severe depression, tachycardia
EENT: Blurred vision, dry glass of water.
hypertension or 3. For I.M. and subcutaneous injection, use at least
mouth, glaucoma,
hypotension, subcortical increased salivation, laryngeal a 21G needle.
brain damage edema, 4. To prevent contact dermatitis, avoid getting
laryngospasm, miosis, mydriasis, solution ion hands.
nasal congestion, 5. Advise patient not to mix oral solution
papillary hypertrophy of the with beverages that contain caffeine (coffee, cola),
 Precautions tongue, parotid gland
tannins (tea), or pectins (apple juice).
enlargement, photophobia,
Cardiovascular diseases, 6. Observe patient carefully when administering
pigmentary retinopathy, ptosis
Parkinson’s disease, angle- ENDO: Breast engorgement medication to ensure that medication is taken not
closure glaucoma, (females), hoarded or cheeked.
myasthenia gravis, galactorrhea, hyperglycemia,
prostatic hyperplasia; hypoglycemia, After Administration
seizure disorders; OB, mastalgia, syndrome of 1. Document medication given.
Lactation: safety not inappropriate ADH 2. Don’t let patient sit or stand up until
secretion
established; enters breat blood pressure and heart rate have
GI: Anorexia, constipation,
milk, not recommended; diarrhea, fecal
returned to baseline.
Geri: dosage reduction impaction, ileus, increased
appetite, nausea, 3. Notify prescriber if patient develops tardive
vomiting dyskinesia or urinary incontinence.
GU: Amenorrhea, bladder 4. Instruct to frequently do good oral hygiene.
paralysis, 5. Be alert for and immediately report signs of
decreased libido, enuresis,
neuroleptic malignant syndrome.
menstrual irregularities,
6. Notify prescriber about worsening psychotic
polyuria, urinary frequency,
urinary symptoms: agitation, catatonic
incontinence, urine retention state, confusion, depression, hallucinations,
HEME: Anemia, aplastic anemia, lethargy, paranoid reactions.
eosinophilia, leukopenia, 7. Monitor temperature; a significant, unexplained
thrombocytopenia, rise can indicate intolerance and a need to
thrombocytopenic or discontinue drug. Notify prescriber immediately if
nonthrombocytopenic this occur
purpura
RESP: Bronchospasm, dyspnea,
increased
respiratory depth
SKIN: Contact dermatitis, dry
skin, eczema,
erythema, jaundice,
photosensitivity, pruritus,
seborrhea
Other: Heatstroke, hyponatremia,
lupuslike symptoms, weight gain.

You might also like